Company / Working Capital per Share
BioMarin Pharmaceutical Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$16.61
FY2025
5-year range
$9.43 / $16.61
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
#26 of 210
Health Care
What the data says
BioMarin Pharmaceutical's working capital per share of $16.61 is higher than 88% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $5.61 in FY2019 to $16.61 in FY2025.
Based on SEC 10-K filings.
16.61 in FY2025 with a 5-year CAGR of +10.3%. Top quartile in the Health Care sector.
Improved from $9.43 to $16.61 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
-88.7% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 20.7% year-over-year.
- Ranks #26 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.61 | +20.7% |
| FY2024 | $13.76 | +45.9% |
| FY2023 | $9.43 | -18.8% |
| FY2022 | $11.61 | +22.1% |
| FY2021 | $9.51 | -6.6% |
| FY2020 | $10.18 | +81.3% |
| FY2019 | $5.61 | -34.7% |
| FY2018 | $8.60 | +8.7% |
| FY2017 | $7.91 | +39.0% |
| FY2016 | $5.69 | +42.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026